![]() ![]() Specifically, Danaher's diagnostics segment included Cepheid, a leader in molecular testing, and its life sciences segment included a variety of companies that worked to develop COVID-19 vaccines and therapies. In 20, Danaher's diagnostic tests and life sciences research tools were widely used in the effort to combat the COVID-19 virus. The Company is comprised of more than 20 operating companies organized under four segments: Biotechnology Life Sciences Diagnostics and Environmental & Applied Solutions. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.ĭanaher designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. A copy of the Complaint can be obtained at To discuss this action, contact Robert S. If you are a shareholder who purchased or otherwise acquired Danaher securities during the Class Period, you have until Septemto ask the Court to appoint you as Lead Plaintiff for the class. The class action, filed in the United States District Court for the District of Columbia, and docketed under 23-cv-02055, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Danaher securities between April 21, 2022, and April 24, 2023, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials. NEW YORK, NY / ACCESSWIRE / J/ Pomerantz LLP announces that a class action lawsuit has been filed against Danaher Corporation ("Danaher" or the "Company") (NYSE:DHR), and certain officers. ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |